MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Century Therapeutics, Inc. Common Stock

IPSC

#3010
Century Therapeutics, Inc. Common Stock
2.32
+6.42%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
2.32
2.32
Intervallo Annuale
0.34
2.71
Variazione giornaliera
+6.42%
Variazione Mensile
-13.43%
Variazione di 6 mesi
+346.15%
Variazione Annuale
+256.92%
Chiusura Precedente
2.18
Open
2.32
Bid
Ask
Low
2.32
High
2.32
Volume
15
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. IPSC
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value 2021202220232024 TTM

Notizie

Investing Investing
IPSC
2026.02.25
TD Cowen avvia la copertura su Century Therapeutics con rating Buy
Investing Investing
IPSC
2026.02.25
TD Cowen initiates Century Therapeutics stock rating at Buy
Investing Investing
IPSC
2026.02.12
Clear Street ribadisce il rating Buy su Century Therapeutics a $6,60
Investing Investing
MSFT ORCL MRK AMGN NVDA
2026.02.09
Oracle, Palantir among market cap stock movers on Monday
Zacks Zacks
IPSC
2026.01.22
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know
Investing Investing
IPSC
2026.01.20
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler
Investing Investing
IPSC
2026.01.08
Clear Street riduce il target di prezzo delle azioni di Century Therapeutics a $6,60
Investing Investing
IPSC
2026.01.08
Century Therapeutics stock price target lowered to $6.60 at Clear Street
Investing Investing
IPSC
2026.01.08
Century Therapeutics ottiene 135 milioni di dollari in posizionamento privato
Investing Investing
IPSC
2026.01.08
Century Therapeutics secures $135 million in private placement
Zacks Zacks
ALKS CRMD IPSC INDV
2026.01.07
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Zacks Zacks
IPSC
2026.01.07
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd